146 related articles for article (PubMed ID: 25832848)
1. Kidney transplant complications from undiagnosed benign prostatic hypertrophy.
Lubetzky M; Ajaimy M; Kamal L; de Boccardo G; Akalin E; Kayler L
Clin Transplant; 2015 Jun; 29(6):539-42. PubMed ID: 25832848
[TBL] [Abstract][Full Text] [Related]
2. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study.
Roehrborn CG; Siami P; Barkin J; Damião R; Major-Walker K; Nandy I; Morrill BB; Gagnier RP; Montorsi F;
Eur Urol; 2010 Jan; 57(1):123-31. PubMed ID: 19825505
[TBL] [Abstract][Full Text] [Related]
3. Impact of medical therapy on transurethral resection of the prostate: two decades of change.
Izard J; Nickel JC
BJU Int; 2011 Jul; 108(1):89-93. PubMed ID: 20883490
[TBL] [Abstract][Full Text] [Related]
4. Incidence, predictors, and associated outcomes of prostatism after kidney transplantation.
Hurst FP; Neff RT; Falta EM; Jindal RM; Lentine KL; Swanson JS; Agodoa LY; Abbott KC
Clin J Am Soc Nephrol; 2009 Feb; 4(2):329-36. PubMed ID: 19176793
[TBL] [Abstract][Full Text] [Related]
5. Increased population use of medications for male lower urinary tract symptoms/benign prostatic hyperplasia correlates with changes in indications for transurethral resection of the prostate.
Ingimarsson JP; Isaksson HJ; Sigbjarnarson HP; Gudmundsson J; Geirsson G
Scand J Urol; 2014 Feb; 48(1):73-8. PubMed ID: 23924152
[TBL] [Abstract][Full Text] [Related]
6. Clinical progression, acute urinary retention, prostate-related surgeries, and costs in patients with benign prostatic hyperplasia taking early versus delayed combination 5α-reductase inhibitor therapy and α-blocker therapy: a retrospective analysis.
Morlock R; Goodwin B; Gomez Rey G; Eaddy M
Clin Ther; 2013 May; 35(5):624-33. PubMed ID: 23583026
[TBL] [Abstract][Full Text] [Related]
7. An algorithm for medical management in male lower urinary tract symptoms.
Djavan B; Margreiter M; Dianat SS
Curr Opin Urol; 2011 Jan; 21(1):5-12. PubMed ID: 21045704
[TBL] [Abstract][Full Text] [Related]
8. Conservative Treatment for Benign Prostatic Hyperplasia in Patients With Bladder Stones.
Yoshida T; Kinoshita H; Nakamoto T; Yanishi M; Sugi M; Murota T; Matsuda T
Urology; 2015 Sep; 86(3):450-3. PubMed ID: 26235850
[TBL] [Abstract][Full Text] [Related]
9. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
van Vuuren SP; Heyns CF; Zarrabi AD
BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
[TBL] [Abstract][Full Text] [Related]
10. Extended-release doxazosin for treatment of renal transplant recipients with benign prostatic hyperplasia.
Zhang Y; Wang Y; Zhang P; Zhang XD; Yang Y
Transplant Proc; 2009 Nov; 41(9):3747-51. PubMed ID: 19917379
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia.
Kellner DS; Armenakas NA; Brodherson M; Heyman J; Fracchia JA
Urology; 2004 Oct; 64(4):703-6. PubMed ID: 15491705
[TBL] [Abstract][Full Text] [Related]
12. Benign prostatic hyperplasia - progress in pathophysiology and management.
Dobrek Ł; Thor PJ
Pol Merkur Lekarski; 2015 Nov; 39(233):263-70. PubMed ID: 26637089
[TBL] [Abstract][Full Text] [Related]
13. Impact of delaying 5-alpha reductase inhibitor therapy in men on alpha-blocker therapy to treat BPH: assessment of acute urinary retention and prostate-related surgery.
Naslund M; Eaddy MT; Hogue SL; Kruep EJ; Shah MB
Curr Med Res Opin; 2009 Nov; 25(11):2663-9. PubMed ID: 19757985
[TBL] [Abstract][Full Text] [Related]
14. Risk stratification for benign prostatic hyperplasia (BPH) treatment.
Emberton M; Fitzpatrick JM; Rees J
BJU Int; 2011 Mar; 107(6):876-80. PubMed ID: 21265993
[TBL] [Abstract][Full Text] [Related]
15. Change in International Prostate Symptom storage subscore after long-term medical therapy in BPH patients: finasteride and alpha-blocker combination therapy in men with moderate-to-severe LUTS/BPH in Korea.
Lee JY; Lee SH; Kim SJ; Kim CS; Lee HM; Kim CI; Chung BH
Urology; 2011 Jan; 77(1):171-6. PubMed ID: 20691464
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of medical treatment in benign prostatic hyperplasia.
Kim CI; Chang HS; Kim BK; Park CH
Urology; 2006 Nov; 68(5):1015-9. PubMed ID: 17095071
[TBL] [Abstract][Full Text] [Related]
17. Transurethral resection of the prostate: failure patterns and surgical outcomes in patients with symptoms refractory to alpha-antagonists.
Blanchard K; Hananel A; Rutchik S; Sullivan J
South Med J; 2000 Dec; 93(12):1192-6. PubMed ID: 11142455
[TBL] [Abstract][Full Text] [Related]
18. Frequency of urinary tract infection in renal transplant recipients and effect on graft function.
Iqbal T; Naqvi R; Akhter SF
J Pak Med Assoc; 2010 Oct; 60(10):826-9. PubMed ID: 21381612
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial.
Roehrborn CG; Barkin J; Siami P; Tubaro A; Wilson TH; Morrill BB; Gagnier RP
BJU Int; 2011 Mar; 107(6):946-54. PubMed ID: 21332630
[TBL] [Abstract][Full Text] [Related]
20. Surgery for benign prostatic hyperplasia: Profile of patients in a tertiary care institution.
Rajeev R; Giri B; Choudhary LP; Kumar R
Natl Med J India; 2017; 30(1):7-10. PubMed ID: 28730999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]